CA lipid core on MRI tied to increased CVD risk: JAMA cardiology

Written By :  MD Bureau
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-01-14 06:19 GMT   |   Update On 2021-01-14 06:19 GMT
Advertisement

High-risk atherosclerotic lesions have been associated with plaque characteristics including the presence of a lipid-rich necrotic core, intraplaque hemorrhage (IPH), thin-fibrous cap, and inflammation. The presence of a lipid core was associated with incident cardiovascular disease events independent of carotid artery wall thickness in asymptomatic individuals and improved risk prediction of incident cardiovascular disease events over traditional cardiovascular risk factors according to study published in the JAMA Cardiology on November 18, 2020.

Advertisement

Previous studies have shown the association between plaque formation and risk of Cardiovascular events and Cerebrovascular events based on Magnetic resonance imaging (MRI) reports. Despite recent progress, it remains unknown whether in an asymptomatic community-based cohort magnetic resonance imaging (MRI) measures of plaque characteristics are independently associated with incident cardiovascular disease (CVD) events when adjusted for carotid artery (CA) wall thickness, a measure of plaque burden. Therefore, researchers of the United States conducted a study to assess associations of CA MRI plaque characteristics with incident CVD events.

Researchers conducted a retrospective analysis of Atherosclerosis Risk in Communities (ARIC) study. The ARIC study was a prospective epidemiologic study in 15 792 adults who were enrolled from 1987 to 1989. Among 15 792 ARIC participants, 2066 were enrolled in the substudy, of whom 1256 had complete data and were eligible for incident CVD analyses. The researchers evaluated the data from January 2017 to August 2020. They assessed the Incident CVD events during a median follow-up time of 10.5 years. They used proportional hazards Cox analyses to ascertain the associations between MRI variables of CA plaque burden and plaque characteristics.

Key findings of the study were:

• The results of the ARIC Carotid MRI substudy add to the growing body of evidence that noninvasive MRI CA measures of plaque burden and plaque characteristics aid in the prediction of incident CVD events.

• Researchers found that carotid artery plaques in participants with incident CVD events (n=172 ) compared with those without (n=1084) had a higher normalized wall index (median [IQR], 0.48 vs 0.43), maximum CA wall thickness (median [IQR], 2.22mm vs 1.96 mm), maximum CA stenosis (median [IQR], 5% vs 0%), and when present, a larger lipid core volume (median [IQR], 0.05 mL vs 0.03 mL), respectively.

• They noted that the presence of a lipid core was independently associated with incident CVD events when adjusted for traditional CVD risk factors and maximum CA wall thickness (HR, 2.48), however, they found no such association in the presence of calcification. This implies an MRI plaque characteristic, is valuable for CVD risk assessment independent of measures of plaque burden.

• They noted that the frequency of intraplaque hemorrhage presence was too small to draw any meaningful conclusions (intraplaque hemorrhage presence: 68 of 1256 participants [5.4%]).

The authors concluded, "The presence of a lipid core is associated with incident CVD events independent of CA wall thickness, a measure of plaque burden, in asymptomatic ARIC participants. Noninvasive MRI carotid plaque characteristics, when present, improved risk prediction of incident CVD events and may be useful imaging surrogates to identify those at higher risk of future CVD events".

For further information:

https://jamanetwork.com/journals/jamacardiology/article-abstract/2772980


Tags:    
Article Source :  JAMA Cardiology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News